Targeting c-Myc with a novel Peptide Nuclear Delivery Device
T. A. Ting, A. A. Chaumet, F. Bard
This paper develops a peptide nuclear delivery device (PNDD) that efficiently delivers c-Myc inhibitors to the nucleus, showing potent antitumor effects in lymphoma cell lines.
bioRxiv · Apr 7, 2020Cell Biology